当サイトはクッキー（Cookies）を使用しています。詳細はプライバシーポリシーをご覧ください。当サイトの閲覧をこのまま続けられた場合は、クッキーの使用に同意したものとさせていただきます。なお、クッキーの設定は随時変更することができます。続ける / 詳細
Setting up the KWM International Center is a significant strategic deployment for the firm.
King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating全文
Analysis of the 2018-19 Australian Federal Budget: significant reforms for corporates, small business and personal tax.
King & Wood Mallesons (KWM) was the biggest winner with 12 awards at the Thomson Reuters ALB China Law Awards 2018 held in Beijing.
We explore how international arbitration has adapted and will continue to adapt in 2018 to global challenges and opportunities.
Stay Focused on the Policies of Hainan's Pharmaceutical and Healthcare Industry.
China's SAFE recently made several enhancements to an existing pilot program regarding the cross-border transfer of Chinese NPLs to foreign investors.
King & Wood Mallesons (KWM) acted as the legal counsel to Ant Financial and Ant International for both the RMB tranche and the USD tranche of this project, advising Ant Financial on a wide range of全文
In this project, KWM acted for FII as the PRC and Hong Kong SAR counsel, and advised on the restructuring, implementing, reforming and various aspects of the issuance and listing.